Based in the United States, Pacific Rim Ventures primarily invests in startups that are 4-5 years old and operate in fields such as Clinical Trials and Health Care. Some of their notable portfolio companies include Bacterial Barcodes, Tranzyme, and Corus Pharma. With an average investment range of $10-50 million, the firm is actively involved in less than 2 investment rounds per year. They have a higher amount of lead investments compared to other organizations and have seen significant exits in 2006. Other notable investors in the same rounds include JPMorgan Partners, Burrill & Company, and Zesiger Capital.